ABBV

AbbVie Declares Quarterly Dividend

The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.73 per share.

AbbVie's Immunology Franchise: From Skyrizi & Rinvoq to What's Next

ABBV's Skyrizi and Rinvoq drives immunology growth, while new indications, acquisitions and partnerships build its next wave.

ABBV Maintained by HSBC -- Price Target Raised to $315

AbbVie Extends Migraine Leadership with Positive Phase 3 Atogepant Results in Menstrual Migraine

AbbVie (NYSE: ABBV) today announced positive topline results from the Phase 3 LUNA study, which evaluated atogepant, a calcitonin gene-related peptide (CGRP) r…

ABBV Maintains Outperform Rating -- Price Target Raised to $260

AbbVie's (ABBV) Botox Just Got A Step Closer To A Fifth Use

AbbVie (NYSE:ABBV) just moved a step closer to expanding one of its most recognizable brands.

Franklin Street Advisors Inc. NC Has $45.71 Million Stock Holdings in AbbVie Inc. $ABBV

Franklin Street Advisors Inc. NC boosted its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 1.4% during the 2nd quarter, according to its most recent dis…

Sax Wealth Advisors LLC Raises Stock Holdings in AbbVie Inc. $ABBV

Sax Wealth Advisors LLC increased its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 24.8% during the second quarter, according to its most recent filing…

Oliver Luxxe Assets LLC Lowers Stock Position in AbbVie Inc. $ABBV

Oliver Luxxe Assets LLC lowered its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 6.4% during the 2nd quarter, according to its most recent di…

Research Analysts' Price Target Changes for August 3rd (ABBV, ABR, ACGL, ADP, AEE, AEM, AEP, AGM, AJG, ALNY)

Research Analysts' price target changes for Monday, August 3rd: AbbVie (NYSE:ABBV) had its target price raised by Cantor Fitzgerald from $265.00 to $285.00. Th…

ABBV Maintained by Cantor Fitzgerald -- Price Target Raised to $265

AbbVie (NYSE:ABBV) Given New $265.00 Price Target at Cantor Fitzgerald

AbbVie (NYSE:ABBV - Get Free Report) had its target price boosted by analysts at Cantor Fitzgerald from $240.00 to $265.00 in a research report issued to clien…

Expanding RINVOQ And SKYRIZI Uses Might Change The Case For Investing In AbbVie (ABBV)

In late June 2026, AbbVie reported multiple product wins, including new pediatric approvals for SKYRIZI, positive CHMP opinions for RINVOQ in alopecia areata a…

Hudson Edge Investment Partners Inc. Has $7.12 Million Holdings in AbbVie Inc. $ABBV

Hudson Edge Investment Partners Inc. increased its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 7.2% during the first quarter, Holdings Channel reports…

(ABBV) and the Role of Price-Sensitive Allocations

Price-action only: Abbvie Inc. (ABBV) movements set the tone for institutional models. (ABBV) and the Role of Price-Sensitive Allocations

Equities Research Analysts' Upgrades for June 27th (AADX, ABBV, ABSI, ACR, AEIS, AEM, AERO, AFCG, AIRS, AKTX)

Equities Research Analysts' upgrades for Saturday, June 27th: Applied Aerospace & Defense (NYSE:AADX) was upgraded by analysts at Wall Street Zen from a sell r…

Stonebridge Financial Group LLC MO Acquires New Stake in AbbVie Inc. $ABBV

Stonebridge Financial Group LLC MO acquired a new stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) in the fourth quarter, HoldingsChannel.com reports.…

Why AbbVie Inc. (ABBV) is One of the Best Healthcare Stocks to Buy for the Long Term

AbbVie Inc. (NYSE:ABBV) is one of the best healthcare stocks to buy for the long term. AbbVie Inc.

3 Reasons to Buy AbbVie Stock (ABBV) Like There's No Tomorrow

How does a rising 3.4% dividend and a growing portfolio of drugs sound?

Stock Analysts' Upgrades for May 9th (ABBV, ABEV, ACB, ACHV, ACMR, ADM, ADTN, AFL, AGL, AGM)

Stock Analysts' upgrades for Saturday, May 9th: AbbVie (NYSE:ABBV) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating. Ambev…

AbbVie (ABBV): Buy, Sell, or Hold Post Q4 Earnings?

Over the past six months, AbbVie has been a great trade, beating the S&P 500 by 5.6%. Its stock price has climbed to $233.25, representing a healthy 11.2% incr…

AbbVie (ABBV) Up 6.1% Since Last Earnings Report: Can It Continue?

AbbVie (ABBV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

AbbVie (ABBV) Suffers a Larger Drop Than the General Market: Key Insights

In the most recent trading session, AbbVie (ABBV) closed at $232.35, indicating a -1.63% shift from the previous trading day.

AbbVie (ABBV) Shares Cross 3% Yield Mark

Looking at the universe of stocks we cover at Dividend Channel, in trading on Friday, shares of AbbVie Inc (Symbol: ABBV) were yielding above the 3% mark based…

See Which Of The Latest 13F Filers Holds ABBV

At Holdings Channel, we have reviewed the latest batch of the 28 most recent 13F filings for the 06/30/2025 reporting period, and noticed that AbbVie Inc (Symb…

Daily Dividend Report: GEV,SNXDAL,ABBV,USB,LLY

GE Vernova today announced that its Board of Directors has declared a $0.25 per share quarterly dividend. The quarterly dividend will be payable on August 18,…

Validea Detailed Fundamental Analysis - ABBV

Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model b…

Noteworthy Tuesday Option Activity: GLW, LOW, ABBV

Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Corning Inc (Symbol: GLW), where a total volum…